Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | RAD51C |
Variant | M1? |
Impact List | unknown |
Protein Effect | unknown |
Gene Variant Descriptions | RAD51C M1? indicates a disruption of the methionine (M) start codon with an unknown translational effect on the Rad51c protein. M1? has not been characterized, however, a version of Rad51c utilizing an alternate methionine at codon 10 decreases mitomycin C sensitivity similar to full-length Rad51c (PMID: 12966089), and therefore, its effect on Rad51c function is unknown (PubMed, Oct 2024). |
Associated Drug Resistance | |
Category Variants Paths |
RAD51C mutant RAD51C M1? |
Transcript | NM_058216.3 |
gDNA | chr17:g.58692644_58692646 |
cDNA | c.1_3 |
Protein | p.M1 |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
XM_017024915.1 | chr17:g.58695137_58695139 | c.1_3 | p.M1 | RefSeq | GRCh38/hg38 |
XM_006722004.4 | chr17:g.58695137_58695139 | c.1_3 | p.M1 | RefSeq | GRCh38/hg38 |
XM_006722001.4 | chr17:g.58692644_58692646 | c.1_3 | p.M1 | RefSeq | GRCh38/hg38 |
XM_011525094.2 | chr17:g.58695137_58695139 | c.1_3 | p.M1 | RefSeq | GRCh38/hg38 |
XM_017024916.1 | chr17:g.58695137_58695139 | c.1_3 | p.M1 | RefSeq | GRCh38/hg38 |
XM_047436505.1 | chr17:g.58692644_58692646 | c.1_3 | p.M1 | RefSeq | GRCh38/hg38 |
XM_006722001.5 | chr17:g.58692644_58692646 | c.1_3 | p.M1 | RefSeq | GRCh38/hg38 |
XM_017024917.1 | chr17:g.58695137_58695139 | c.1_3 | p.M1 | RefSeq | GRCh38/hg38 |
XM_011525092.2 | chr17:g.58695137_58695139 | c.1_3 | p.M1 | RefSeq | GRCh38/hg38 |
XM_006722004.3 | chr17:g.58695137_58695139 | c.1_3 | p.M1 | RefSeq | GRCh38/hg38 |
XM_017024914.1 | chr17:g.58695137_58695139 | c.1_3 | p.M1 | RefSeq | GRCh38/hg38 |
XM_006722002.5 | chr17:g.58692644_58692646 | c.1_3 | p.M1 | RefSeq | GRCh38/hg38 |
XM_006722005.3 | chr17:g.58695137_58695139 | c.1_3 | p.M1 | RefSeq | GRCh38/hg38 |
NM_058216.2 | chr17:g.58692644_58692646 | c.1_3 | p.M1 | RefSeq | GRCh38/hg38 |
XM_017024918.2 | chr17:g.58695137_58695139 | c.1_3 | p.M1 | RefSeq | GRCh38/hg38 |
XM_006722002.4 | chr17:g.58692644_58692646 | c.1_3 | p.M1 | RefSeq | GRCh38/hg38 |
XM_011525093.2 | chr17:g.58695137_58695139 | c.1_3 | p.M1 | RefSeq | GRCh38/hg38 |
NM_002876.3 | chr17:g.58692644_58692646 | c.1_3 | p.M1 | RefSeq | GRCh38/hg38 |
NM_058216.3 | chr17:g.58692644_58692646 | c.1_3 | p.M1 | RefSeq | GRCh38/hg38 |
XM_017024919.1 | chr17:g.58695137_58695139 | c.1_3 | p.M1 | RefSeq | GRCh38/hg38 |
XM_011525094.3 | chr17:g.58695137_58695139 | c.1_3 | p.M1 | RefSeq | GRCh38/hg38 |
NM_002876.4 | chr17:g.58692644_58692646 | c.1_3 | p.M1 | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|